The protective effects of beta-mangostin against sodium iodate-induced retinal ROS-mediated apoptosis through MEK/ERK and p53 signaling pathways

Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natu...

Full description

Saved in:
Bibliographic Details
Published inFood & function Vol. 14; no. 24; pp. 1896 - 199
Main Authors Chang, Yuan-Yen, Wang, Meilin, Yeh, Jui-Hsuan, Tsou, Shang-Chun, Chen, Tzu-Chun, Hsu, Min-Yen, Lee, Yi-Ju, Wang, Inga, Lin, Hui-Wen
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 11.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens . The influence of BM on NaIO 3 -induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO 3 -induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO 3 ; it was mediated by significantly reduced NaIO 3 -upregulated ROS, cellular H 2 O 2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO 3 -induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO 3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO 3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO 3 -induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces.
AbstractList Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens . The influence of BM on NaIO 3 -induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO 3 -induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO 3 ; it was mediated by significantly reduced NaIO 3 -upregulated ROS, cellular H 2 O 2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO 3 -induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO 3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO 3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO 3 -induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.
Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens . The influence of BM on NaIO 3 -induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO 3 -induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO 3 ; it was mediated by significantly reduced NaIO 3 -upregulated ROS, cellular H 2 O 2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO 3 -induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO 3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO 3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO 3 -induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways. Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces.
Previous studies have indicated that NaIO induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from . The influence of BM on NaIO -induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO -induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO ; it was mediated by significantly reduced NaIO -upregulated ROS, cellular H O production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO -induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO -induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.
Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens. The influence of BM on NaIO3-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO3-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO3; it was mediated by significantly reduced NaIO3-upregulated ROS, cellular H2O2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO3-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO3-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens. The influence of BM on NaIO3-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO3-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO3; it was mediated by significantly reduced NaIO3-upregulated ROS, cellular H2O2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO3-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO3-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.
Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular degeneration (AMD) due to the selective retinal pigment epithelium (RPE) cell damage it induces. Beta-mangostin (BM) is a xanthone-type natural compound isolated from Cratoxylum arborescens. The influence of BM on NaIO3-induced oxidative stress damage in ARPE-19 cells has not yet been elucidated. In this study, we investigated how BM protects ARPE-19 cells from NaIO3-induced ROS-mediated apoptosis. Our results revealed that BM notably improved cell viability and prevented ARPE-19 cell mitochondrial dysfunction mediated-apoptosis induced by NaIO3; it was mediated by significantly reduced NaIO3-upregulated ROS, cellular H2O2 production and improved downregulated glutathione and catalase activities. Furthermore, we found that BM could suppress the expression of Bax, cleaved PARP, and cleaved caspase-3 by decreasing phosphorylation of MEK/ERK and p53 expression in NaIO3-induced ARPE-19 cells. At the same time, we also used MEK inhibitors (PD98059) to confirm the above phenomenon. Moreover, our animal experiments revealed that BM prevented NaIO3 from causing retinal deformation; it led to thicker outer and inner nuclear layers and downregulated cleaved caspase-3 expression compared to the group receiving NaIO3 only. Collectively, these results suggest that BM can protect the RPE and retina from NaIO3-induced apoptosis through ROS-mediated mitochondrial dysfunction involving the MEK/ERK and p53 signaling pathways.
Author Yeh, Jui-Hsuan
Chen, Tzu-Chun
Hsu, Min-Yen
Wang, Inga
Wang, Meilin
Chang, Yuan-Yen
Lin, Hui-Wen
Tsou, Shang-Chun
Lee, Yi-Ju
AuthorAffiliation Department of Nutrition
Rehabilitation Sciences & Technology
Chung Shan Medical University
Chung Shan Medical University and Clinical Laboratory
University of Wisconsin-Milwaukee
Chung Shan Medical University Hospital
Asia University
Department of Microbiology and Immunology
Department of Pathology
School of Medicine
Institute of Medicine
Department of Optometry
Chung Shan Medical University and Department of Ophthalmology
AuthorAffiliation_xml – sequence: 0
  name: Chung Shan Medical University Hospital
– sequence: 0
  name: Department of Microbiology and Immunology
– sequence: 0
  name: Chung Shan Medical University
– sequence: 0
  name: School of Medicine
– sequence: 0
  name: Department of Pathology
– sequence: 0
  name: Rehabilitation Sciences & Technology
– sequence: 0
  name: Chung Shan Medical University and Clinical Laboratory
– sequence: 0
  name: Institute of Medicine
– sequence: 0
  name: Chung Shan Medical University and Department of Ophthalmology
– sequence: 0
  name: University of Wisconsin-Milwaukee
– sequence: 0
  name: Asia University
– sequence: 0
  name: Department of Nutrition
– sequence: 0
  name: Department of Optometry
Author_xml – sequence: 1
  givenname: Yuan-Yen
  surname: Chang
  fullname: Chang, Yuan-Yen
– sequence: 2
  givenname: Meilin
  surname: Wang
  fullname: Wang, Meilin
– sequence: 3
  givenname: Jui-Hsuan
  surname: Yeh
  fullname: Yeh, Jui-Hsuan
– sequence: 4
  givenname: Shang-Chun
  surname: Tsou
  fullname: Tsou, Shang-Chun
– sequence: 5
  givenname: Tzu-Chun
  surname: Chen
  fullname: Chen, Tzu-Chun
– sequence: 6
  givenname: Min-Yen
  surname: Hsu
  fullname: Hsu, Min-Yen
– sequence: 7
  givenname: Yi-Ju
  surname: Lee
  fullname: Lee, Yi-Ju
– sequence: 8
  givenname: Inga
  surname: Wang
  fullname: Wang, Inga
– sequence: 9
  givenname: Hui-Wen
  surname: Lin
  fullname: Lin, Hui-Wen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37990840$$D View this record in MEDLINE/PubMed
BookMark eNptkl1rFTEQhoNUbK298V4JeCPC2myS_chlqacqrRyoFbxb5iSze1J2k22SVfov_MlGT1uhODczMM87zNdzsue8Q0Jelux9yYQ6NqL3TFR1C0_IAWeSF3XFvu_dx1LV--QoxmuWTSjVqvYZ2ReNUqyV7ID8utoinYNPqJP9gRT7PkeR-p5uMEExgRt8TNZRGMC6mGj0xi4Ttd5AwsI6s2g0NGBmYKSX66_FhMbmnKEw-zn5aCNN2-CXYUu_rM6PV5fnFJyhcyVotENWWTfQGdL2J9zGF-RpD2PEozt_SL6dra5OPxUX64-fT08uCi1Ek4q2KaXmQsiSg-Hc9HXVb6TGumEbxZDXpZRMilbUJZqGca2ywlRStlCaPLs4JG93dfPwNwvG1E02ahxHcOiX2PFW8bpSlVAZffMIvfZLyH1nSjHGVdM2LFOv76hlkzfQzcFOEG67-11n4N0O0MHHGLB_QErW_bll90Gcrf_e8iTD7BGsbYJkvUsB7Ph_yaudJET9UPrfe4jfgrupiQ
CitedBy_id crossref_primary_10_3389_fimmu_2024_1440309
crossref_primary_10_3390_antiox13050538
crossref_primary_10_1002_tox_24501
crossref_primary_10_1016_j_tiv_2025_106047
crossref_primary_10_1016_j_biopha_2024_117346
crossref_primary_10_1002_tox_24416
crossref_primary_10_1016_j_bioorg_2024_107968
Cites_doi 10.1038/s41419-021-03673-0
10.1016/j.dental.2005.11.037
10.1016/j.phrs.2021.106032
10.1155/2015/919058
10.1002/tox.22449
10.2147/DDDT.S80625
10.1016/j.preteyeres.2020.100858
10.1159/000092991
10.3390/nu13124411
10.1016/j.neurobiolaging.2005.05.012
10.1186/s13578-022-00879-3
10.1089/ars.2021.0072
10.1186/s12929-019-0531-z
10.1016/j.biopha.2023.114710
10.1016/j.arr.2022.101619
10.3390/antiox12071379
10.1016/j.cellsig.2022.110487
10.3390/antiox10121870
10.1016/j.freeradbiomed.2022.12.004
10.1016/j.biocel.2014.11.018
10.1016/j.jep.2014.02.051
10.1016/j.arr.2023.102077
10.1039/D2FO02788G
10.7150/thno.71038
10.1089/ars.2009.3001
10.1371/journal.pone.0143663
10.1016/j.foodchem.2012.02.075
10.1038/cdd.2017.169
10.1039/np9961300265
10.1038/s41598-019-52172-y
10.1093/jmcb/mjac074
10.1248/bpb.34.47
10.1155/2021/8852759
10.2147/DDDT.S278414
10.3390/biom10030492
10.3390/antiox10071125
10.1002/ptr.2730
10.3390/ijms22094945
10.1179/1476830512Y.0000000011
10.3390/ijms22084056
10.1371/journal.pone.0030874
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2023
Copyright_xml – notice: Copyright Royal Society of Chemistry 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7T7
7TO
7U7
8FD
C1K
FR3
H94
P64
7X8
DOI 10.1039/d3fo03568a
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Oncogenes and Growth Factors Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Diet & Clinical Nutrition
EISSN 2042-650X
EndPage 199
ExternalDocumentID 37990840
10_1039_D3FO03568A
d3fo03568a
Genre Journal Article
GroupedDBID ---
-JG
0-7
0R~
4.4
53G
705
7~J
AAEMU
AAHBH
AAIWI
AAJAE
AANOJ
AARTK
AAWGC
AAXHV
ABASK
ABDVN
ABEMK
ABJNI
ABPDG
ABRYZ
ABXOH
ACGFS
ACLDK
ACPRK
ADMRA
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRAH
AFVBQ
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
APEMP
ASKNT
AUDPV
AZFZN
BLAPV
BSQNT
C6K
EBS
ECGLT
EE0
EF-
GGIMP
H13
HZ~
H~N
J3I
O-G
O9-
P2P
RAOCF
RCNCU
RNS
RPMJG
RRC
RSCEA
RVUXY
SKF
SKH
SKJ
SKM
SKR
SKZ
SLC
SLF
AAYXX
AFRZK
AKMSF
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7T7
7TO
7U7
8FD
C1K
FR3
H94
P64
7X8
ID FETCH-LOGICAL-c337t-8714c233412ad22df65fb4ce670b90e261440438361ed702c9871d5448a1d9083
ISSN 2042-6496
2042-650X
IngestDate Fri Jul 11 07:01:14 EDT 2025
Mon Jun 30 11:56:22 EDT 2025
Wed Feb 19 02:08:28 EST 2025
Tue Jul 01 03:03:01 EDT 2025
Thu Apr 24 23:09:36 EDT 2025
Tue Dec 17 20:58:39 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 24
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c337t-8714c233412ad22df65fb4ce670b90e261440438361ed702c9871d5448a1d9083
Notes https://doi.org/10.1039/d3fo03568a
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6395-4280
0000-0002-0738-8509
PMID 37990840
PQID 2900297870
PQPubID 2047526
PageCount 14
ParticipantIDs crossref_primary_10_1039_D3FO03568A
proquest_journals_2900297870
pubmed_primary_37990840
proquest_miscellaneous_2892659539
crossref_citationtrail_10_1039_D3FO03568A
rsc_primary_d3fo03568a
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-11
PublicationDateYYYYMMDD 2023-12-11
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-11
  day: 11
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle Food & function
PublicationTitleAlternate Food Funct
PublicationYear 2023
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Nauman (D3FO03568A/cit11/1) 2022; 175
Chan (D3FO03568A/cit17/1) 2019; 26
Sidahmed (D3FO03568A/cit37/1) 2016; 10
Huang (D3FO03568A/cit24/1) 2017; 32
Kim (D3FO03568A/cit44/1) 2015; 59
Xing (D3FO03568A/cit9/1) 2021; 13
Syam (D3FO03568A/cit38/1) 2014; 153
Feher (D3FO03568A/cit27/1) 2006; 27
Alam (D3FO03568A/cit36/1) 2023; 163
Hsu (D3FO03568A/cit4/1) 2021; 10
Lee (D3FO03568A/cit13/1) 2019; 2019
Zou (D3FO03568A/cit29/1) 2023; 194
Deng (D3FO03568A/cit30/1) 2021; 2021
Yang (D3FO03568A/cit42/1) 2023
Bai (D3FO03568A/cit1/1) 2022; 77
Li (D3FO03568A/cit14/1) 2020; 14
Obolskiy (D3FO03568A/cit34/1) 2009; 23
Yuan (D3FO03568A/cit22/1) 2020; 2020
Wang (D3FO03568A/cit23/1) 2022; 12
Reyes-Fermín (D3FO03568A/cit40/1) 2012; 15
Duan (D3FO03568A/cit33/1) 2011; 34
Kaarniranta (D3FO03568A/cit20/1) 2020; 79
Feher (D3FO03568A/cit19/1) 2006; 27
Janhom (D3FO03568A/cit41/1) 2015; 2015
Lee (D3FO03568A/cit32/1) 2020; 10
Lu (D3FO03568A/cit10/1) 2021; 22
Aubrey (D3FO03568A/cit43/1) 2018; 25
Mueller (D3FO03568A/cit26/1) 2012; 7
Zheng (D3FO03568A/cit18/1) 2023; 14
Hao (D3FO03568A/cit21/1) 2022; 14
Ding (D3FO03568A/cit2/1) 2023; 91
Chang (D3FO03568A/cit47/1) 2015; 10
Weecharangsan (D3FO03568A/cit39/1) 2006; 15
Nauman (D3FO03568A/cit35/1) 2022; 175
Chang (D3FO03568A/cit3/1) 2021; 22
Samuelsen (D3FO03568A/cit45/1) 2007; 23
Kumar (D3FO03568A/cit15/1) 2021; 12
Chuang (D3FO03568A/cit5/1) 2021; 10
Zeng (D3FO03568A/cit46/1) 2022; 12
Ahn (D3FO03568A/cit8/1) 2019; 9
Acosta-Casique (D3FO03568A/cit16/1) 2023; 101
Chae (D3FO03568A/cit12/1) 2012; 134
Kushwah (D3FO03568A/cit7/1) 2023; 12
Kietzmann (D3FO03568A/cit25/1) 2010; 13
Gordon (D3FO03568A/cit6/1) 1996; 13
Chen (D3FO03568A/cit31/1) 2022; 37
Kaarniranta (D3FO03568A/cit28/1) 2020; 79
References_xml – volume: 12
  start-page: 389
  year: 2021
  ident: D3FO03568A/cit15/1
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-03673-0
– volume: 23
  start-page: 34
  year: 2007
  ident: D3FO03568A/cit45/1
  publication-title: Dent. Mater.
  doi: 10.1016/j.dental.2005.11.037
– volume: 175
  start-page: 106032
  year: 2022
  ident: D3FO03568A/cit11/1
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2021.106032
– volume: 2015
  start-page: 919058
  year: 2015
  ident: D3FO03568A/cit41/1
  publication-title: J. Toxicol.
  doi: 10.1155/2015/919058
– volume: 32
  start-page: 2360
  year: 2017
  ident: D3FO03568A/cit24/1
  publication-title: Environ. Toxicol.
  doi: 10.1002/tox.22449
– volume: 10
  start-page: 297
  year: 2016
  ident: D3FO03568A/cit37/1
  publication-title: Drug Des., Dev. Ther.
  doi: 10.2147/DDDT.S80625
– volume: 79
  start-page: 100858
  year: 2020
  ident: D3FO03568A/cit28/1
  publication-title: Prog. Retinal Eye Res.
  doi: 10.1016/j.preteyeres.2020.100858
– volume: 15
  start-page: 281
  year: 2006
  ident: D3FO03568A/cit39/1
  publication-title: Med. Princ. Pract.
  doi: 10.1159/000092991
– volume: 13
  start-page: 4411
  issue: 12
  year: 2021
  ident: D3FO03568A/cit9/1
  publication-title: Nutrients
  doi: 10.3390/nu13124411
– volume: 2019
  start-page: 3640753
  year: 2019
  ident: D3FO03568A/cit13/1
  publication-title: Oxid. Med. Cell. Longevity
– volume: 27
  start-page: 983
  year: 2006
  ident: D3FO03568A/cit27/1
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2005.05.012
– volume: 12
  start-page: 133
  year: 2022
  ident: D3FO03568A/cit23/1
  publication-title: Cell Biosci.
  doi: 10.1186/s13578-022-00879-3
– volume: 37
  start-page: 115
  issue: 1–3
  year: 2022
  ident: D3FO03568A/cit31/1
  publication-title: Antioxid. Redox Signaling
  doi: 10.1089/ars.2021.0072
– volume: 26
  start-page: 40
  year: 2019
  ident: D3FO03568A/cit17/1
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-019-0531-z
– volume: 163
  start-page: 114710
  year: 2023
  ident: D3FO03568A/cit36/1
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2023.114710
– volume: 77
  start-page: 101619
  year: 2022
  ident: D3FO03568A/cit1/1
  publication-title: Ageing Res. Rev.
  doi: 10.1016/j.arr.2022.101619
– volume: 12
  start-page: 1379
  issue: 7
  year: 2023
  ident: D3FO03568A/cit7/1
  publication-title: Antioxidants
  doi: 10.3390/antiox12071379
– volume: 101
  start-page: 110487
  year: 2023
  ident: D3FO03568A/cit16/1
  publication-title: Cell. Signalling
  doi: 10.1016/j.cellsig.2022.110487
– volume: 10
  start-page: 1870
  year: 2021
  ident: D3FO03568A/cit5/1
  publication-title: Antioxidants
  doi: 10.3390/antiox10121870
– volume: 194
  start-page: 209
  year: 2023
  ident: D3FO03568A/cit29/1
  publication-title: Free Radicals Biol. Med.
  doi: 10.1016/j.freeradbiomed.2022.12.004
– volume: 59
  start-page: 41
  year: 2015
  ident: D3FO03568A/cit44/1
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2014.11.018
– volume: 153
  start-page: 435
  year: 2014
  ident: D3FO03568A/cit38/1
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2014.02.051
– volume: 91
  start-page: 102077
  year: 2023
  ident: D3FO03568A/cit2/1
  publication-title: Ageing Res. Rev.
  doi: 10.1016/j.arr.2023.102077
– volume: 14
  start-page: 399
  issue: 1
  year: 2023
  ident: D3FO03568A/cit18/1
  publication-title: Food Funct.
  doi: 10.1039/D2FO02788G
– volume: 12
  start-page: 6705
  issue: 15
  year: 2022
  ident: D3FO03568A/cit46/1
  publication-title: Theranostics
  doi: 10.7150/thno.71038
– volume: 175
  start-page: 106032
  year: 2022
  ident: D3FO03568A/cit35/1
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2021.106032
– volume: 13
  start-page: 395
  year: 2010
  ident: D3FO03568A/cit25/1
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2009.3001
– volume: 10
  start-page: e0143663
  year: 2015
  ident: D3FO03568A/cit47/1
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0143663
– volume: 134
  start-page: 397
  year: 2012
  ident: D3FO03568A/cit12/1
  publication-title: Food Chem.
  doi: 10.1016/j.foodchem.2012.02.075
– volume: 27
  start-page: 983
  year: 2006
  ident: D3FO03568A/cit19/1
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2005.05.012
– volume: 25
  start-page: 104
  year: 2018
  ident: D3FO03568A/cit43/1
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2017.169
– volume: 13
  start-page: 265
  year: 1996
  ident: D3FO03568A/cit6/1
  publication-title: Nat. Prod. Rep.
  doi: 10.1039/np9961300265
– volume: 9
  start-page: 15696
  issue: 1
  year: 2019
  ident: D3FO03568A/cit8/1
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-52172-y
– volume: 14
  start-page: mjac074
  issue: 10
  year: 2022
  ident: D3FO03568A/cit21/1
  publication-title: J. Mol. Cell Biol.
  doi: 10.1093/jmcb/mjac074
– volume: 2020
  start-page: 7962393
  year: 2020
  ident: D3FO03568A/cit22/1
  publication-title: Oxid. Med. Cell. Longevity
– volume: 34
  start-page: 47
  year: 2011
  ident: D3FO03568A/cit33/1
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.34.47
– volume: 2021
  start-page: 8852759
  year: 2021
  ident: D3FO03568A/cit30/1
  publication-title: Oxid. Med. Cell. Longevity
  doi: 10.1155/2021/8852759
– year: 2023
  ident: D3FO03568A/cit42/1
  publication-title: J. Adv. Res.
– volume: 14
  start-page: 5315
  year: 2020
  ident: D3FO03568A/cit14/1
  publication-title: Drug Des., Dev. Ther.
  doi: 10.2147/DDDT.S278414
– volume: 10
  start-page: 492
  year: 2020
  ident: D3FO03568A/cit32/1
  publication-title: Biomolecules
  doi: 10.3390/biom10030492
– volume: 10
  start-page: 1125
  year: 2021
  ident: D3FO03568A/cit4/1
  publication-title: Antioxidants
  doi: 10.3390/antiox10071125
– volume: 23
  start-page: 1047
  year: 2009
  ident: D3FO03568A/cit34/1
  publication-title: Phytother. Res.
  doi: 10.1002/ptr.2730
– volume: 22
  start-page: 4945
  issue: 9
  year: 2021
  ident: D3FO03568A/cit10/1
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22094945
– volume: 79
  start-page: 100858
  year: 2020
  ident: D3FO03568A/cit20/1
  publication-title: Prog. Retinal Eye Res.
  doi: 10.1016/j.preteyeres.2020.100858
– volume: 15
  start-page: 34
  year: 2012
  ident: D3FO03568A/cit40/1
  publication-title: Nutr. Neurosci.
  doi: 10.1179/1476830512Y.0000000011
– volume: 22
  start-page: 4056
  year: 2021
  ident: D3FO03568A/cit3/1
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22084056
– volume: 7
  start-page: e30874
  year: 2012
  ident: D3FO03568A/cit26/1
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0030874
SSID ssj0000399898
Score 2.3764296
Snippet Previous studies have indicated that NaIO 3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular...
Previous studies have indicated that NaIO induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular...
Previous studies have indicated that NaIO3 induces intracellular reactive oxygen species (ROS) production and has been used as a model for age-related macular...
SourceID proquest
pubmed
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1896
SubjectTerms Age
Age related diseases
Animals
Apoptosis
Caspase 3 - genetics
Caspase 3 - metabolism
Caspase-3
Catalase
Cell viability
Cellular manufacture
Damage
Down-regulation
Epithelium
Eye diseases
Glutathione
Hydrogen peroxide
Hydrogen Peroxide - metabolism
Intracellular signalling
Macular degeneration
MEK inhibitors
Mitochondrial Diseases
Mitogen-Activated Protein Kinase Kinases - metabolism
Oxidative Stress
p53 Protein
Phosphorylation
Reactive oxygen species
Reactive Oxygen Species - metabolism
Retina
Retinal Pigment Epithelium
Signal Transduction
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - metabolism
Title The protective effects of beta-mangostin against sodium iodate-induced retinal ROS-mediated apoptosis through MEK/ERK and p53 signaling pathways
URI https://www.ncbi.nlm.nih.gov/pubmed/37990840
https://www.proquest.com/docview/2900297870
https://www.proquest.com/docview/2892659539
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9sIL4jYoDGQEQkJVWGLn5sfStVR0a6XRau1T5CTOFqlLqjURgl_AIz-Z48S5VOvD4MWqTmwn6vl8fI59Lgh9cN3AYoL5muk7HBrX1phrmJrNIxG4luNEfuFtMbXHC_Pb0lp2Or9bXkt55n8Ofu2NK_kfrgIN-CqjZP-Bs_WkQIDfwF9ogcPQ3pvHKtGCdABq-Wb4IuPaDU-uUljCSY9f8Rj0wN42DeP8phen0s7XwBzP5fW_DGSUSunF7LtWRJJILZRv0k2WynQlVSmf8-EEPnV4MSmTC1i0J50_eBnPDorkD_5z29Z1RzJhskSW3Dvb9_2D6pB6lfNEWzXBaJeKfi7idVxTV-K6jB-JtfE2b9A836Z5cXgrp9MG13nSPsIgVLqDKBFbSDoiY4RAVVyWm9IeWiWqzRYkidkSvIbulpVx72wJOpUZVUMapTq1bLe18VWX_dOZN1qcnXnz4XL-AB0SMDhAYh72J1--XtbndTCNLLUpaxVWX1Zlu6XspJl-V7-5Y7SACnNblZYpVJj5Y_RI2R64XwLpCeqI5CnqnsYiwx-xShC7xtOqPsMz9AcAhhuAYQUwnEZ4F2BYAQyXAMO7AMMKYLgNMFwDDCuAYQDYCcALA7wwwAvX8MIVvJ6jxWg4H4w1VcJDCyh1MthrDTMgFFQlwkNCwsi2It8MhO3oPtMFkccRRbZc2xCho5OAwYjQMk2XGyED8-AIHSRpIl4izCyqc7nnmNQ2w4BwXTCYMDIM37BhbBd9qv54L1D57WWZlbVX-FlQ5p3S0axgUr-L3td9N2VWl729jiv-eWrVbz3Cinpvrnzhu_oxyGR50cYTkebQx2VE5umkrItelHyvX0Md0P9cE0YfARBqcgOgV_eY9jV62KyjY3SQ3ebiDSjHmf9W4fYvyHq7ow
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+protective+effects+of+beta-mangostin+against+sodium+iodate-induced+retinal+ROS-mediated+apoptosis+through+MEK%2FERK+and+p53+signaling+pathways&rft.jtitle=Food+%26+function&rft.au=Chang%2C+Yuan-Yen&rft.au=Wang%2C+Meilin&rft.au=Yeh%2C+Jui-Hsuan&rft.au=Tsou%2C+Shang-Chun&rft.date=2023-12-11&rft.issn=2042-650X&rft.eissn=2042-650X&rft.volume=14&rft.issue=24&rft.spage=10896&rft_id=info:doi/10.1039%2Fd3fo03568a&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6496&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6496&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6496&client=summon